| Selenium Supplementation for Prevention of Colorectal Adenomas and Risk of Associated Type 2 Diabetes 2016 · selenium · Men and women aged 40–80 years following colonoscopic removal of colorectal adenomas | 200 mcg | 1004 days | 685 |
| Phase 3 clinical trial investigating the effect of selenium supplementation in men at high-risk for prostate cancer 2013 · selenium 200 µg/day · Men younger than 80 with a negative prostate biopsy and at least one prostate cancer risk indicator (PSA >4 ng/ml, suspicious DRE, or PSA velocity >0.75 ng/ml/year) | 200 mcg | 154 weeks | 234 |
| Protective role of selenium against hepatitis B virus and primary liver cancer in Qidong 1997 · selenium yeast tablet · 226 hepatitis B surface antigen-positive people; age and sex not reported | 200 mcg | 4 years | 113 |
| Effects of selenium supplementation on pregnancy outcomes and disease progression in HIV-infected pregnant women in Lagos: A randomized controlled trial 2021 · selenium arm · HIV-infected pregnant women aged 15–49 years with singleton pregnancies at 14–27 weeks of gestation | 200 mcg | 17 weeks | 90 |
| The influence of selenium supplementation on postpartum thyroid status in pregnant women with thyroid peroxidase autoantibodies 2007 · group S1 · Euthyroid pregnant women positive for thyroid peroxidase antibodies (TPOAb+) | 200 mcg | — | 77 |
| Selenium and Vitamin E for Prevention of Non-Muscle-Invasive Bladder Cancer Recurrence and Progression: A Randomized Clinical Trial 2023 · selenium and vitamin E placebo · Adults aged 18 years or older with newly diagnosed, pathologically confirmed non-muscle-invasive bladder cancer | 200 mcg | 548 days | 65 |
| The effect of selenium yeast in the prevention of adverse reactions related to platinum-based combination therapy in patients with malignant tumors 2023 · observation group · Patients with malignant tumors receiving platinum-containing combination chemotherapy; age and sex not reported | 200 mcg | — | 43 |
| Selenium Supplementation and the Effects on Reproductive Outcomes, Biomarkers of Inflammation, and Oxidative Stress in Women with Polycystic Ovary Syndrome 2016 · selenium group · Women aged 18–40 with polycystic ovary syndrome (PCOS) | 200 mcg | 8 weeks | 32 |
| The favourable effects of long-term selenium supplementation on regression of cervical tissues and metabolic profiles of patients with cervical intraepithelial neoplasia: a randomised, double-blind, placebo-controlled trial 2015 · Se supplements · Women diagnosed with cervical intraepithelial neoplasia grade 1 (CIN1) | 200 mcg | 26 weeks | 28 |
| Baseline characteristics and the effect of selenium supplementation on cancer incidence in a randomized clinical trial: a summary report of the Nutritional Prevention of Cancer Trial 2002 · selenium supplementation · Residents of the Eastern United States with a history of nonmelanoma skin cancer; age and sex not specified | 200 mcg | — | — |
| Impact of a selenium chemoprevention clinical trial on hospital admissions of HIV-infected participants 2002 · selenium group · HIV-positive men and women | 200 mcg | 2 years | — |
| Selenium supplementation, baseline plasma selenium status and incidence of prostate cancer: an analysis of the complete treatment period of the Nutritional Prevention of Cancer Trial 2003 · selenium supplementation · Residents of the Eastern USA at risk of recurrent nonmelanoma skin cancer; age and sex not specified | 200 mcg | — | — |
| Selenium supplementation and secondary prevention of nonmelanoma skin cancer in a randomized trial 2003 · selenium group · Patients in the Eastern United States with a history of nonmelanoma skin cancer | 200 mcg | — | — |
| Selenium supplementation and colorectal adenomas: an analysis of the nutritional prevention of cancer trial 2006 · selenium treatment · Participants in the Nutritional Prevention of Cancer trial; age and condition not specified in the abstract | 200 mcg | — | — |
| A preliminary report on the intervention trials of primary liver cancer in high-risk populations with nutritional supplementation of selenium in China 1991 · HBsAg-positive carriers receiving Se-yeast · Hepatitis B virus surface antigen carriers in a high-risk area for primary liver cancer | 200 mcg | 4 years | — |
| A preliminary report on the intervention trials of primary liver cancer in high-risk populations with nutritional supplementation of selenium in China 1991 · High-incidence-family members receiving Se-yeast · Members of families with high primary liver cancer incidence | 200 mcg | 2 years | — |
| Effects of long-term selenium supplementation on the incidence of type 2 diabetes: a randomized trial 2007 · selenium recipients · Mostly older adults without type 2 diabetes at baseline, recruited from dermatology clinics | 200 mcg | 2811 days | — |
| Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT) 2011 · selenium group · Healthy men at average risk of prostate cancer; age 50 or older for African Americans and 55 or older for others | 200 mcg | 2008 days | — |
| Evaluation of vitamin E and selenium supplementation for the prevention of bladder cancer in SWOG coordinated SELECT 2012 · selenium · Men aged 50 years or older if Black and 55 years or older otherwise, without prior prostate cancer diagnosis | 200 mcg | 6 years | — |
| Effect of micronutrient supplementation on disease progression in asymptomatic, antiretroviral-naive, HIV-infected adults in Botswana: a randomized clinical trial 2013 · selenium alone · Adults aged 18 years or older, men and nonpregnant women, with asymptomatic HIV infection, CD4 count greater than 350/μL, and no prior antiretroviral therapy | 200 mcg | 2 years | — |
| Plasma tocopherols and risk of prostate cancer in the Selenium and Vitamin E Cancer Prevention Trial (SELECT) 2014 · selenium · African-American men aged 50 years or older and non-African-American men aged 55 years or older, without specified prostate cancer at enrollment | 200 mcg | — | — |
| Selenium- or Vitamin E-Related Gene Variants, Interaction with Supplementation, and Risk of High-Grade Prostate Cancer in SELECT 2016 · selenium alone · Caucasian men without prostate cancer at baseline, included in the SELECT analysis | 200 mcg | — | — |
| Effect of long-term selenium supplementation on mortality: Results from a multiple-dose, randomised controlled trial 2018 · 200 µg selenium/d group · Male and female volunteers aged 60–74 years with relatively low selenium status | 200 mcg | 5 years | — |
| Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group 1996 · selenium group · Adults aged 18–80 years with a history of basal cell or squamous cell carcinoma of the skin | 200 mcg | 1643 days | — |
| Reduction of cancer risk with an oral supplement of selenium 1997 · Se-enriched yeast · Patients with a history of basal or squamous cell carcinoma of the skin | 200 mcg | — | — |
| Reduction of cancer mortality and incidence by selenium supplementation 1997 · Se-enriched yeast · Patients with histories of basal or squamous cell carcinomas of the skin; age and sex not reported | 200 mcg | — | — |
| Decreased incidence of prostate cancer with selenium supplementation: results of a double-blind cancer prevention trial 1998 · selenium-treated group · Men with a history of basal cell or squamous cell carcinoma | 200 mcg | 1643 days | — |
| Phase 3 clinical trial investigating the effect of selenium supplementation in men at high-risk for prostate cancer 2013 · selenium 400 µg/day · Men younger than 80 with a negative prostate biopsy and at least one prostate cancer risk indicator (PSA >4 ng/ml, suspicious DRE, or PSA velocity >0.75 ng/ml/year) | 400 mcg | 1066 days | 233 |
| Reduced Cardiovascular Mortality 10 Years after Supplementation with Selenium and Coenzyme Q10 for Four Years: Follow-Up Results of a Prospective Randomized Double-Blind Placebo-Controlled Trial in Elderly Citizens 2015 · Active treatment · Elderly Swedish community-dwelling adults; mean age 78 years; men and women; described as healthy, with low baseline selenium status | 200 mcg | 4 years | 221 |
| Still reduced cardiovascular mortality 12 years after supplementation with selenium and coenzyme Q10 for four years: A validation of previous 10-year follow-up results of a prospective randomized double-blind placebo-controlled trial in elderly 2018 · Active treatment group · Elderly healthy Swedish community-dwelling adults; mean age 78 years, men and women | 200 mcg | 1461 days | 221 |
| Supplementation with Selenium and Coenzyme Q10 Reduces Cardiovascular Mortality in Elderly with Low Selenium Status. A Secondary Analysis of a Randomised Clinical Trial 2016 · active treatment group · Adults aged 70–80 years in Sweden, without a stated requirement for a diagnosed condition; participants were analysed in strata by baseline serum selenium concentration. | 200 mcg | 4 years | 219 |
| Selenium supplementation and premature (pre-labour) rupture of membranes: a randomised double-blind placebo-controlled trial 2010 · selenium group · Primigravid pregnant women in the first trimester | 100 mcg | — | 83 |
| Selenium supplementation and the incidence of preeclampsia in pregnant Iranian women: a randomized, double-blind, placebo-controlled pilot trial 2010 · selenium · Primigravid pregnant women in the first trimester, described as high-risk | 100 mcg | — | 83 |
| Selenium supplement in the prevention of pregnancy induced hypertension 1994 · selenium supplement group · pregnant women with high-risk factors for pregnancy-induced hypertension | 100 mcg | 8 weeks | 52 |
| Intervention trial with selenium for the prevention of lung cancer among tin miners in Yunnan, China. A pilot study 1990 · Se-supplemented group · Healthy male tin miners with low selenium status; age not reported | 300 mcg | 1 year | — |
| Effect of long-term selenium supplementation on mortality: Results from a multiple-dose, randomised controlled trial 2018 · 100 µg selenium/d group · Male and female volunteers aged 60–74 years with relatively low selenium status | 100 mcg | 5 years | — |
| Effect of long-term selenium supplementation on mortality: Results from a multiple-dose, randomised controlled trial 2018 · 300 µg selenium/d group · Male and female volunteers aged 60–74 years with relatively low selenium status | 300 mcg | 5 years | — |
| A randomized controlled trial of vitamin E and selenium on rate of decline in lung function 2015 · Selenium · Men aged 50 years and older without clinical evidence of prostate cancer | 200 mcg | 5 years | 759 |
| Efficacy of selenium and/or N-acetyl-cysteine for improving semen parameters in infertile men: a double-blind, placebo controlled, randomized study 2009 · selenium group · Infertile men with idiopathic oligo-asthenoteratospermia | 200 mcg | 26 weeks | 116 |
| The effect of selenium supplementation on disease activity and immune-inflammatory biomarkers in patients with mild-to-moderate ulcerative colitis: a randomized, double-blind, placebo-controlled clinical trial 2023 · selenium group · Patients with mild-to-moderate active ulcerative colitis | 200 mcg | 10 weeks | 50 |
| Selenium supplementation improves the nutritional status of hemodialysis patients: a randomized, double-blind, placebo-controlled trial 2013 · selenium group · Patients on stable hemodialysis for at least 3 months, without acute illness or active infections | 200 mcg | 12 weeks | 40 |
| The Antioxidant Effect of Selenium on Succinylcholine-related Myalgia After Adult Sinuscopies: Randomized Controlled Double-Blind Trial 2021 · selenium group · Adults scheduled for sinuscopies | 200 mcg | 1 day | 40 |
| Selenium-Enriched Yeast Supplementation and Its Influence on Nerve Function Parameters and Oxidative Stress Markers in Diabetic Peripheral Neuropathy: A Randomized Placebo-Controlled Study 2025 · selenium · Adults aged 40–70 years with diabetic peripheral neuropathy | 200 mcg | 8 weeks | 25 |
| Selenium supplementation has beneficial and detrimental effects on immunity to influenza vaccine in older adults 2017 · SeY-200/d · Adults aged 50–64 years with suboptimal selenium status (plasma selenium <110 ng/mL) | 200 mcg | 12 weeks | 23 |
| The Effects of Selenium Supplementation on Clinical Symptoms and Gene Expression Related to Inflammation and Vascular Endothelial Growth Factor in Infertile Women Candidate for In Vitro Fertilization 2020 · selenium group · Infertile women with polycystic ovary syndrome who were candidates for in vitro fertilization; age not reported | 200 mcg | 8 weeks | 18 |
| Selenium supplementation in inactive moderate to severe Graves' orbitopathy patients: a randomized controlled trial 2024 · selenium group · Adults with inactive moderate-to-severe Graves' orbitopathy | 200 mcg | 26 weeks | 13 |
| Psychological burden in the era of HAART: impact of selenium therapy 2003 · selenium therapy · HIV-positive drug users | 200 mcg | 1 year | — |
| Selenium supplementation improves antioxidant capacity in vitro and in vivo in patients with coronary artery disease The SElenium Therapy in Coronary Artery disease Patients (SETCAP) Study 2008 · 200 μg sodium selenite group · Adults with stable coronary artery disease; median age 66 years, 18.5% women | 200 mcg | 12 weeks | — |
| Selenium and the course of mild Graves' orbitopathy 2011 · selenium · Patients with mild Graves' orbitopathy | 200 mcg | 26 weeks | — |
| Impact of Coenzyme Q10 and Selenium on Seminal Fluid Parameters and Antioxidant Status in Men with Idiopathic Infertility 2021 · selenium · Men with idiopathic oligoasthenoteratospermia | 200 mcg | 90 days | — |
| Oral selenium improved the disease activity in patients with mild Graves' orbitopathy 2021 · Group B · Adults aged 18 years or older with mild Graves' orbitopathy | 200 mcg | 26 weeks | — |
| [The prevention of primary liver cancer by selenium in high risk populations] 2000 · experimental group · Males aged 20–65 who were HBsAg-positive, AFP-negative, had normal liver function, and lived in a high-risk area for liver cancer | 500 mcg | 3 years | 1,112 |
| Improved cardiovascular health by supplementation with selenium and coenzyme Q10: applying structural equation modelling (SEM) to clinical outcomes and biomarkers to explore underlying mechanisms in a prospective randomized double-blind placebo-controlled intervention project in Sweden 2022 · Active treatment group · Adults aged 70–88 years with low selenium status and age-related low coenzyme Q10 levels | 400 mcg | 4 years | 221 |
| Selenium Supplementation for Prevention of Late-Onset Sepsis in Very Low Birth Weight Preterm Neonates 2016 · test group · Preterm neonates weighing <1500 g and born before 32 weeks’ gestation, asymptomatic at birth and without maternal sepsis risk factors | 10 mcg | 4 weeks | 45 |
| [Preliminary observations on effect of selenium yeast on high risk populations with primary liver cancer] 1992 · selenium group among HBsAg carriers · HBsAg carriers at high risk of primary liver cancer | 200 g | 4 years | — |
| [Preliminary observations on effect of selenium yeast on high risk populations with primary liver cancer] 1992 · selenium group among first-relatives in the pedigree with high incidence of primary liver cancer · First-relatives in a pedigree with high incidence of primary liver cancer | 200 g | 2 years | — |
| Effect of micronutrient supplementation on infection in institutionalized elderly subjects: a controlled trial 1997 · trace elements/zinc · Institutionalized elderly subjects in a geriatric center; low serum zinc and selenium were common at baseline | 100 mcg | 2 years | — |
| Improved Health-Related Quality of Life, and More Days out of Hospital with Supplementation with Selenium and Coenzyme Q10 Combined. Results from a Double Blind, Placebo-Controlled Prospective Study 2015 · active substance group · community-dwelling elderly adults; mean age 77 years; 51% male | 200 mcg | 1461 days | 221 |
| Efficacy of selenium and/or N-acetyl-cysteine for improving semen parameters in infertile men: a double-blind, placebo controlled, randomized study 2009 · selenium plus N-acetyl-cysteine group · Infertile men with idiopathic oligo-asthenoteratospermia | 200 mcg | 26 weeks | 116 |
| Effect of supplementation with selenium on postpartum depression: a randomized double-blind placebo-controlled trial 2011 · selenium group · Iranian primigravid women in the first trimester of pregnancy | 100 mcg | — | 83 |
| The efficacy of selenium in prevention of oral mucositis in patients undergoing hematopoietic SCT: a randomized clinical trial 2013 · selenium group · Patients with leukemia undergoing allogeneic HSCT | 400 mcg | — | 37 |
| Selenium supplementation has beneficial and detrimental effects on immunity to influenza vaccine in older adults 2017 · SeY-100/d · Adults aged 50–64 years with suboptimal selenium status (plasma selenium <110 ng/mL) | 100 mcg | 12 weeks | 21 |
| The Effects of Zinc and Selenium Co-Supplementation on Resting Metabolic Rate, Thyroid Function, Physical Fitness, and Functional Capacity in Overweight and Obese People under a Hypocaloric Diet: A Randomized, Double-Blind, and Placebo-Controlled Trial 2023 · supplementation group · Adults aged 18–40, men and women with overweight or obesity (BMI ≥25) | 200 mcg | 8 weeks | 14 |
| Effects of Brazil nut consumption on selenium status and cognitive performance in older adults with mild cognitive impairment: a randomized controlled pilot trial 2016 · Brazil nut group · Older adults with mild cognitive impairment; mean age 77.7 years; both sexes | 289 mcg | 26 weeks | 11 |
| Effect of selenium supplementation for protection of salivary glands from iodine-131 radiation damage in patients with differentiated thyroid cancer 2017 · selenium group · Patients with differentiated thyroid cancer after total thyroidectomy, receiving iodine-131 treatment; age and sex not reported | 300 mcg | 10 days | 8 |
| Effects of dietary selenium on sperm motility in healthy men 2001 · High-selenium group · Healthy men; age and sex beyond male not specified | 297 mcg | 99 days | — |
| The impact of selenium supplementation on mood 1991 · selenium · British population; adults, age and sex not specified; no diagnosed condition stated | 100 mcg | 5 weeks | — |
| The effect of selenium supplementation on DTH skin responses in healthy North American men 2009 · high-Se yeast · healthy men; age range not reported | 300 mcg | 48 weeks | — |
| Selenium supplementation improves mood in a double-blind crossover trial 1990 · selenium · British subjects; age and sex not specified, with possible subclinical selenium deficiency | 100 mcg | 5 weeks | — |
| Investigation of the Effect of Oral Selenium on the Reduction of Clinical Symptoms and Joint Pain in Patients With Rheumatoid Arthritis in the Iranian Population 2023 · selenium group · Patients with moderate or severe rheumatoid arthritis; age and sex not reported | 400 mcg | 12 weeks | — |
| Mediterranean diet, selenium and Graves' ophthalmopathy: a prospective, randomized, single-center study 2025 · MD group · Adults with untreated mild active Graves' ophthalmopathy and stable thyroid function | 178 mcg | 24 weeks | — |
| A trial of the effect of micronutrient supplementation on treatment outcome, T cell counts, morbidity, and mortality in adults with pulmonary tuberculosis 2008 · micronutrients · Adults aged 18–65 with pulmonary tuberculosis, including HIV-positive and HIV-negative participants | 100 mcg | 187 weeks | 443 |
| An intervention study to prevent gastric cancer by micro-selenium and large dose of allitridum 2004 · intervention group · Adults aged 35–74 with at least one risk criterion: a history of stomach disorder, a family history of tumour, or smoking and/or alcohol consumption | 50 mcg | 30 days | 2,526 |
| Selenium and Vitamin E for Prevention of Non-Muscle-Invasive Bladder Cancer Recurrence and Progression: A Randomized Clinical Trial 2023 · selenium and vitamin E · Adults aged 18 years or older with newly diagnosed, pathologically confirmed non-muscle-invasive bladder cancer | 200 mcg | 548 days | 69 |
| [Alcohol-induced toxic hepatitis--a "free radical" associated disease. Lowering fatality by adjuvant antioxidant therapy] 1993 · antioxidant group · Patients with acute alcohol-toxic hepatitis, clinical Child/Pugh severity grades B and C; age and sex not reported | 200 mcg | — | 31 |
| Adding L-Carnitine and Selenium to Methimazole in Graves' Disease: A Prospective Randomized Trial on Thyroid Markers and Quality of Life 2025 · Intervention Group · Adults with newly diagnosed overt Graves’ disease; mean age 48.51 years; 46 women and 14 men in the study overall | 83 mcg | 2 years | 30 |
| Interferon/antioxidant combination therapy for chronic hepatitis C--a controlled pilot trial 1999 · group B · Interferon-naive patients with chronic hepatitis C; age and sex not reported | 400 mcg | 24 weeks | 8 |
| Interferon/antioxidant combination therapy for chronic hepatitis C--a controlled pilot trial 1999 · group C · Interferon-naive patients with chronic hepatitis C; age and sex not reported | 400 mcg | 24 weeks | 8 |
| Total and cancer mortality after supplementation with vitamins and minerals: follow-up of the Linxian General Population Nutrition Intervention Trial 2009 · Factor D · Adults in Linxian, China; age and sex details not given | 50 mcg | 313 weeks | — |
| Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT) 2011 · selenium plus vitamin E group · Healthy men at average risk of prostate cancer; age 50 or older for African Americans and 55 or older for others | 200 mcg | 2008 days | — |
| Evaluation of vitamin E and selenium supplementation for the prevention of bladder cancer in SWOG coordinated SELECT 2012 · selenium plus vitamin E · Men aged 50 years or older if Black and 55 years or older otherwise, without prior prostate cancer diagnosis | 200 mcg | 6 years | — |
| Effect of micronutrient supplementation on disease progression in asymptomatic, antiretroviral-naive, HIV-infected adults in Botswana: a randomized clinical trial 2013 · multivitamins plus selenium · Adults aged 18 years or older, men and nonpregnant women, with asymptomatic HIV infection, CD4 count greater than 350/μL, and no prior antiretroviral therapy | 200 mcg | 2 years | — |
| Plasma tocopherols and risk of prostate cancer in the Selenium and Vitamin E Cancer Prevention Trial (SELECT) 2014 · selenium plus vitamin E · African-American men aged 50 years or older and non-African-American men aged 55 years or older, without specified prostate cancer at enrollment | 200 mcg | — | — |
| Use of selenium-silymarin mix reduces lower urinary tract symptoms and prostate specific antigen in men 2013 · selenium-silymarin group · Men with lower urinary tract symptoms and benign prostatic hyperplasia, with PSA ≤2.5 ng/ml | 240 mcg | 26 weeks | 26 |
| Impact of nano-selenium supplementation add-on sertraline on depressive symptoms and oxidative stress in patients with major depressive disorder: a triple-blind randomized controlled trial 2026 · nano-selenium · Adults newly diagnosed with major depressive disorder | 55 mcg | 12 weeks | 21 |
| The safety and efficacy of a silymarin and selenium combination in men after radical prostatectomy - a six month placebo-controlled double-blind clinical trial 2010 · SM-Se group · Men 2–3 months after radical prostatectomy | 240 mcg | 26 weeks | 19 |
| Selenium supplementation has beneficial and detrimental effects on immunity to influenza vaccine in older adults 2017 · SeY-50/d · Adults aged 50–64 years with suboptimal selenium status (plasma selenium <110 ng/mL) | 50 mcg | 12 weeks | 18 |
| Colostrinin: a proline-rich polypeptide (PRP) complex isolated from ovine colostrum for treatment of Alzheimer's disease. A double-blind, placebo-controlled study 1999 · Selenium · Patients with mild to moderate Alzheimer's disease | 50 mcg | 1 year | 15 |
| Effects of dietary selenium on sperm motility in healthy men 2001 · Low-selenium group · Healthy men; age and sex beyond male not specified | 13 mcg | 99 days | — |
| Reduction of postoperative lymphedema after oral tumor surgery with sodium selenite 2005 · Oral sodium selenite · Patients undergoing oral tumor surgery; age and sex not reported | 1 mg | 3 weeks | — |
| Selenium supplementation improves antioxidant capacity in vitro and in vivo in patients with coronary artery disease The SElenium Therapy in Coronary Artery disease Patients (SETCAP) Study 2008 · 500 μg sodium selenite group · Adults with stable coronary artery disease; median age 66 years, 18.5% women | 500 mcg | 12 weeks | — |
| Effects of Helicobacter pylori treatment and vitamin and garlic supplementation on gastric cancer incidence and mortality: follow-up of a randomized intervention trial 2019 · Vitamin supplementation · Rural Chinese adults aged 35–64 at high risk of gastric cancer, with and without H pylori infection | 75 mcg | 2665 days | 1,677 |
| Effects of fortified milk on morbidity in young children in north India: community based, randomised, double masked placebo controlled trial 2007 · fortified milk · Children aged 1–3 years in a peri-urban settlement in north India | 4.2 mcg | 1 year | 316 |
| Antioxidant supplement and long-term reduction of recurrent adenomas of the large bowel. A double-blind randomized trial 2013 · active compound · Patients who had undergone polypectomy and were undergoing post-polypectomy endoscopic follow-up | 200 mcg | 5 years | 164 |
| Effect of an Immune-Boosting, Antioxidant and Anti-Inflammatory Food Supplement in Hospitalized COVID-19 Patients: A Prospective Randomized Pilot Study 2023 · intervention group · Adults aged 18 years or older hospitalized with PCR-confirmed COVID-19 who required more than 48 hours of admission | 8.25 mcg | — | 78 |
| "The SU.VI.MAX Study": a primary prevention trial using nutritional doses of antioxidant vitamins and minerals in cardiovascular diseases and cancers. SUpplementation on VItamines et Minéraux AntioXydants 1999 · antioxidant vitamins and minerals supplementation · Women aged 35 to 60 years and men aged 45 to 60 years, without a stated condition | 100 mcg | 8 years | — |
| Effects of multimicronutrient supplementation on helminth reinfection: a randomized, controlled trial in Kenyan schoolchildren 2003 · multimicronutrient supplementation · Schoolchildren in Nyanza Province, Kenya; age and sex not specified | 40 mcg | 335 days | — |
| The SU.VI.MAX Study: a randomized, placebo-controlled trial of the health effects of antioxidant vitamins and minerals 2004 · antioxidant supplement group · French women aged 35–60 and men aged 45–60 in the general population | 100 mcg | 2739 days | — |
| Antioxidant status and risk of cancer in the SU.VI.MAX study: is the effect of supplementation dependent on baseline levels? 2005 · daily antioxidant supplementation · French adults: women aged 35–60 years and men aged 45–60 years | 100 mcg | 2739 days | — |
| [The SU.VI.MAX study, a randomized, placebo-controlled trial on the effects of antioxidant vitamins and minerals on health] 2006 · antioxidant supplementation · Middle-aged adults in the general population | 100 mcg | 2738 days | — |
| Randomized, double-blind, placebo-controlled trial of selenium supplements among HIV-infected pregnant women in Tanzania: effects on maternal and child outcomes 2008 · selenium group · Infants born to women with HIV in the selenium group; follow-up after birth | 200 mcg | — | — |
| Incidence of cancers, ischemic cardiovascular diseases and mortality during 5-year follow-up after stopping antioxidant vitamins and minerals supplements: a postintervention follow-up in the SU.VI.MAX Study 2010 · antioxidant supplementation · French women aged 35–60 years and men aged 45–60 years | 100 mcg | 2738 days | — |
| Effect of micronutrient supplementation on infection in institutionalized elderly subjects: a controlled trial 1997 · combination of trace elements and vitamins · Institutionalized elderly subjects in a geriatric center; low serum vitamin C, zinc and selenium were common at baseline | 100 mcg | 2 years | — |
| Growth and recurrence of colorectal polyps: a double-blind 3-year intervention with calcium and antioxidants 1998 · active medication · Adults with colorectal polyps; age range and sex not stated | 101 mcg | 3 years | — |
| Effects of vitamin C, vitamin E, zinc gluconate, and selenomethionine supplementation on muscle function and oxidative stress biomarkers in patients with facioscapulohumeral dystrophy: a double-blind randomized controlled clinical trial 2015 · supplemented group · Adults with facioscapulohumeral muscular dystrophy (FSHD) | 200 mcg | 17 weeks | 26 |
| A randomized controlled trial of vitamin E and selenium on rate of decline in lung function 2015 · Vitamin E and Selenium · Men aged 50 years and older without clinical evidence of prostate cancer | 200 mcg | 5 years | 709 |
| A Randomized Controlled Multicenter Trial of an Investigational Liquid Nutritional Formula in Women with Cyclic Breast Pain Associated with Fibrocystic Breast Changes 2018 · Experimental formula · Women aged 18–55 with cyclic mastalgia associated with fibrocystic breast changes; generally healthy and not pregnant | 70 mcg | — | 93 |
| The Effects of Probiotic and Selenium Co-supplementation on Clinical and Metabolic Scales in Chronic Schizophrenia: a Randomized, Double-blind, Placebo-Controlled Trial 2021 · Probiotic plus selenium · People with chronic schizophrenia | 200 mcg | 12 weeks | 30 |
| Effect of Selenium and Vitamin E on the Level of Sperm HSPA2+, Intracellular Superoxide Anion and Chromatin Integrity in Idiopathic Asthenoteratozoospermia: A Double-Blind, Randomized, Placebo- Controlled Trial 2021 · treatment group · men with idiopathic asthenoteratozoospermia; age range not reported | 200 mcg | 90 days | 30 |
| The effects of probiotic and selenium co-supplementation on mental health parameters and metabolic profiles in type 2 diabetic patients with coronary heart disease: A randomized, double-blind, placebo-controlled trial 2019 · Probiotic and selenium co-supplementation · Adults with type 2 diabetes and coronary heart disease | 200 mcg | 12 weeks | 27 |
| Probiotic and selenium co-supplementation, and the effects on clinical, metabolic and genetic status in Alzheimer's disease: A randomized, double-blind, controlled trial 2019 · selenium plus probiotic · Patients with Alzheimer's disease; age range and sex not reported | 200 mcg | 12 weeks | 27 |
| Clinical and biochemical effects of coenzyme Q(10), vitamin E, and selenium supplementation to psoriasis patients 2009 · EP1 · Patients with severe erythrodermic psoriasis | 48 mcg | 30 days | — |
| Clinical and biochemical effects of coenzyme Q(10), vitamin E, and selenium supplementation to psoriasis patients 2009 · PsA1 · Patients with severe arthropathic psoriasis | 48 mcg | 5 weeks | — |
| Effect of supplementation with Se-enriched yeast and factors influencing Se concentration in plasma of transplant recipients 2009 · group 1 (Se-supplemented) · Organ transplant recipients; age and sex not specified | 200 mcg | 3 years | 91 |
| Selenium supplementation to chronic kidney disease patients on hemodialysis does not induce the synthesis of plasma glutathione peroxidase 2009 · selenium-supplemented group · patients with chronic kidney disease receiving hemodialysis | 200 mcg | 90 days | 30 |
| Dose-dependent effects of selenized yeast on total selenium levels in prostatic tissue of men with prostate cancer 2011 · 200 μg high selenized yeast group · Men under 80 with biopsy-proven, non-metastatic prostate adenocarcinoma undergoing radical prostatectomy | 200 mcg | 6 weeks | 19 |
| Selenium supplementation of children in a selenium-deficient area in China: blood selenium levels and glutathione peroxidase activities 2000 · selenite Se · Children aged 14–16 years in a selenium-deficient area of China, described as healthy | 200 mcg | 12 weeks | 10 |
| Selenium supplementation of children in a selenium-deficient area in China: blood selenium levels and glutathione peroxidase activities 2000 · Se-yeast · Children aged 14–16 years in a selenium-deficient area of China, described as healthy | 200 mcg | 12 weeks | 10 |
| Prostatic and peripheral blood selenium levels after oral supplementation 2003 · selenium supplementation · Men undergoing transurethral resection of the prostate for benign prostatic hyperplasia | 200 mcg | 30 days | — |
| Supplementation with wheat selenium induces a dose-dependent response in serum and urine of a Se-replete population 1992 · 200 micrograms Se daily · Healthy Norwegian women; age not reported | 200 mcg | 6 weeks | — |
| Establishing optimal selenium status: results of a randomized, double-blind, placebo-controlled trial 2010 · 200 microg Se-yeast group · Healthy men and women aged 50–64 years | 200 mcg | 12 weeks | — |
| Differential responses to selenomethionine supplementation by sex and genotype in healthy adults 2012 · 200 μg/d as L-SeMet · Healthy American adults; men and women | 200 mcg | 1 year | — |
| Comparative effects of two different forms of selenium on oxidative stress biomarkers in healthy men: a randomized clinical trial 2014 · low dose SY (SY200) · Healthy nonsmoking men aged 20–79 years; analyzed participants were aged 23–78 years and had no chronic disease | 200 mcg | 39 weeks | — |
| Comparative effects of two different forms of selenium on oxidative stress biomarkers in healthy men: a randomized clinical trial 2014 · SeMet · Healthy nonsmoking men aged 20–79 years; analyzed participants were aged 23–78 years and had no chronic disease | 200 mcg | 39 weeks | — |
| Long-term supplementation with selenate and selenomethionine: urinary excretion by New Zealand women 1997 · Se-enriched yeast (selenomethionine, SeMet) group · New Zealand women aged 18–23 years | 200 mcg | 32 weeks | — |
| Long-term supplementation with selenate and selenomethionine: urinary excretion by New Zealand women 1997 · selenate group · New Zealand women aged 18–23 years | 200 mcg | 32 weeks | — |
| Micronutrient fortified milk improves iron status, anemia and growth among children 1-4 years: a double masked, randomized, controlled trial 2010 · Micronutrient-fortified milk (MN group) · Children aged 1–4 years in India; many had anemia, iron deficiency, or growth faltering | 4.2 mcg | 1 year | 316 |
| Additional Effects of Nutritional Antioxidant Supplementation on Peripheral Muscle during Pulmonary Rehabilitation in COPD Patients: A Randomized Controlled Trial 2019 · PR antioxidant group · Adults aged 40–78 with stable COPD | 50 mcg | 4 weeks | 32 |
| Consumption of Nutritionally Enriched Hen Eggs Enhances Endothelium-Dependent Vasodilation via Cyclooxygenase Metabolites in Healthy Young People-A Randomized Study 2023 · Nutri4 (enriched eggs) · Healthy young adults aged 18–30 years, both sexes, with normal blood pressure and BMI | 60 mcg | 3 weeks | 20 |
| Supportive treatment of vascular dysfunction in pediatric subjects with obesity: the OBELIX study 2022 · Treatment group · Children aged 6–17 years with obesity (BMI above the 95th percentile for age) | 55 mcg | 26 weeks | 16 |
| The effects of antioxidant vitamin supplementation on expiratory flow rates at rest and during exercise 2015 · antioxidant vitamin supplementation (AVS) · healthy nonsmoking adults, 5 men and 5 women, consuming fewer than 5 servings of fruit and vegetables per day | 50 mg | 4 weeks | 10 |
| Changes in ventilatory threshold at high altitude: effect of antioxidants 2006 · antioxidant (AO) supplement group · Physically fit males aged 25 ± 5 years exposed to high altitude at 4300 m | 100 mcg | 5 weeks | — |
| French adults' cognitive performance after daily supplementation with antioxidant vitamins and minerals at nutritional doses: a post hoc analysis of the Supplementation in Vitamins and Mineral Antioxidants (SU.VI.MAX) trial 2011 · antioxidant supplementation · French adults aged 45–60 years enrolled in the SU.VI.MAX study | 100 mcg | 2922 days | — |
| Effect of selenium supplementation on CD4+ T-cell recovery, viral suppression and morbidity of HIV-infected patients in Rwanda: a randomized controlled trial 2015 · selenium · HIV-infected adults aged 21 years or older in Rwanda, not yet eligible for antiretroviral therapy, with baseline CD4+ T-cell counts of 400–650 cells/μl | 200 mcg | 2 years | 151 |
| Effect of supplementation with high-selenium yeast on plasma lipids: a randomized trial 2011 · 200 mcg/d selenium · Volunteers aged 60 to 74 years | 200 mcg | 26 weeks | 127 |
| A Protective Role for Arachidonic Acid Metabolites against Advanced Colorectal Adenoma in a Phase III Trial of Selenium 2021 · selenium group · Adults with a colorectal adenoma at study entry; age and sex range not specified | 200 mcg | 1 year | 125 |
| Does selenium supplementation affect thyroid function? Results from a randomized, controlled, double-blinded trial in a Danish population 2015 · 200 μg selenium-enriched yeast · Males and females aged 60–74 years with suboptimal dietary selenium intake | 200 mcg | 5 years | 122 |
| [Effects of selenium supplementation on antibodies of autoimmune thyroiditis] 2012 · selenium-treated · People aged 15–70 with autoimmune thyroiditis and TPOAb above 300 U/ml, including 49 with euthyroidism or subclinical hypothyroidism and 28 with hypothyroidism | 200 mcg | 26 weeks | 77 |
| Selenomethionine treatment in patients with autoimmune thyroiditis: a prospective, quasi-randomised trial 2012 · Se6 · Patients with chronic autoimmune (Hashimoto's) thyroiditis | 200 mcg | 26 weeks | 46 |
| Effect of selenium on thyroid autoimmunity and regulatory T cells in patients with Hashimoto's thyroiditis: A prospective randomized-controlled trial 2021 · Se-treated group · Adults with Hashimoto’s thyroiditis without levothyroxine treatment; age and sex range not specified | 200 mcg | 26 weeks | 43 |
| Effects of selenium and vitamin C on the serum level of antithyroid peroxidase antibody in patients with autoimmune thyroiditis 2019 · Group one (GI) · People aged 15–78 years with autoimmune thyroiditis; sex not specified | 200 mcg | 90 days | 38 |
| Selenium supplementation in patients with autoimmune thyroiditis decreases thyroid peroxidase antibodies concentrations 2002 · selenium group · Female patients with autoimmune thyroiditis and elevated thyroid peroxidase and/or thyroglobulin antibodies; mean age 47.5 years | 200 mcg | 90 days | 36 |
| Metabolic response to selenium supplementation in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial 2015 · selenium supplements · Women aged 18–40 with diagnosed polycystic ovary syndrome (PCOS) | 200 mcg | 8 weeks | 35 |
| Effects of selenium supplementation on glucose homeostasis, inflammation, and oxidative stress in gestational diabetes: Randomized, double-blind, placebo-controlled trial 2015 · selenium supplements · Pregnant women with gestational diabetes mellitus, gestational weeks 24–28 | 200 mcg | 6 weeks | 35 |
| Effect of Selenium Supplementation on Glycemic Control and Lipid Profiles in Patients with Diabetic Nephropathy 2016 · selenium group · Patients with diabetic nephropathy; age and sex not reported | 200 mcg | 12 weeks | 30 |
| Selenium Supplementation Affects Insulin Resistance and Serum hs-CRP in Patients with Type 2 Diabetes and Coronary Heart Disease 2016 · Group A · Adults aged 40–85 with type 2 diabetes and coronary heart disease | 200 mcg | 8 weeks | 30 |
| The effects of selenium supplementation on biomarkers of inflammation and oxidative stress in patients with diabetic nephropathy: a randomised, double-blind, placebo-controlled trial 2016 · Se supplements · Patients with diabetic nephropathy | 200 mcg | 12 weeks | 30 |
| The effects of selenium administration on carotid intima-media thickness and metabolic status in diabetic hemodialysis patients: A randomized, double-blind, placebo-controlled trial 2022 · selenium group · Diabetic hemodialysis patients; age and sex not specified | 200 mcg | 24 weeks | 30 |
| The Effect of Selenium Supplementation on Clinical Outcomes, Metabolic Profiles, and Pulsatility Index of the Uterine Artery in High-Risk Mothers in Terms of Preeclampsia Screening with Quadruple Test: a Randomized, Double-Blind, Placebo-Controlled Clinical Trial : Selenium and preeclampsia 2023 · Selenium group · Pregnant women aged 18–40 years at high risk for preeclampsia on quadruple-test screening | 200 mcg | 12 weeks | 30 |
| A randomized-controlled, double-blind study of the impact of selenium supplementation on thyroid autoimmunity and inflammation with focus on the GPx1 genotypes 2015 · selenium (SeMet) group · Patients with chronic autoimmune thyroiditis and positive antiTPO; age and sex not reported | 200 mcg | 90 days | 28 |
| Effects of selenium supplementation on glucose homeostasis and free androgen index in women with polycystic ovary syndrome: A randomized, double blinded, placebo controlled clinical trial 2016 · selenium · Women aged 18–42 with polycystic ovary syndrome diagnosed by Rotterdam criteria | 200 mcg | 12 weeks | 26 |
| Selenium supplementation lowers insulin resistance and markers of cardio-metabolic risk in patients with congestive heart failure: a randomised, double-blind, placebo-controlled trial 2018 · Selenium group · Adults aged 45–85 years with congestive heart failure | 200 mcg | 12 weeks | 26 |
| Probiotic and selenium co-supplementation, and the effects on clinical, metabolic and genetic status in Alzheimer's disease: A randomized, double-blind, controlled trial 2019 · selenium · Patients with Alzheimer's disease; age range and sex not reported | 200 mcg | 12 weeks | 26 |
| Effects of selenium supplementation on selenoprotein gene expression and response to influenza vaccine challenge: a randomised controlled trial 2011 · 200 µg/day Se-yeast · Men and women aged 50–64 with suboptimal selenium status (plasma selenium <110 ng/ml) | 200 mcg | 12 weeks | 23 |
| The effect of selenium supplementation in the prevention of DNA damage in white blood cells of hemodialyzed patients: a pilot study 2011 · selenium · Patients with chronic kidney disease receiving regular hemodialysis; mean age 59.6 years; sex not reported | 200 mcg | 90 days | 22 |
| [Assessment of some oxidative stress parameters in bronchial asthma patients beyond add-on selenium supplementation] 2007 · All patients receiving selenium · Adults with bronchial asthma and selenium deficiency; 7 men and 13 women | 200 mcg | 16 weeks | 20 |
| The Effects of Selenium Supplementation on Gene Expression Related to Insulin and Lipid in Infertile Polycystic Ovary Syndrome Women Candidate for In Vitro Fertilization: a Randomized, Double-Blind, Placebo-Controlled Trial 2018 · selenium group · Infertile women with polycystic ovary syndrome who were candidates for in vitro fertilization | 200 mcg | 8 weeks | 20 |
| Effect of Selenomethionine- Enriched Yeast on Hypothyroidism Patients 2025 · intervention (Selenium) · Patients with Hashimoto's thyroiditis | 200 mcg | 60 days | 20 |
| The Effects of Selenium Supplementation on Gene Expression Related to Insulin and Lipid Metabolism, and Pregnancy Outcomes in Patients with Gestational Diabetes Mellitus: a Randomized, Double-Blind, Placebo-Controlled Trial 2020 · selenium group · Pregnant patients with gestational diabetes mellitus | 200 mcg | 6 weeks | 18 |
| Effects of Selenium Supplementation on Metabolic Status in Patients Undergoing for Coronary Artery Bypass Grafting (CABG) Surgery: a Randomized, Double-Blind, Placebo-Controlled Trial 2019 · Selenium group · Patients aged 40–85 undergoing coronary artery bypass grafting (CABG) surgery | 200 mcg | 4 weeks | 17 |
| Selenomethionine treatment in patients with autoimmune thyroiditis: a prospective, quasi-randomised trial 2012 · Se3 · Patients with chronic autoimmune (Hashimoto's) thyroiditis | 200 mcg | 90 days | 15 |
| Supplementation with selenium-rich bread does not influence platelet aggregation in healthy volunteers 1992 · selenium-rich bread supplementation group · healthy volunteers | 200 mcg | 6 weeks | 6 |
| Effects of a high-selenium yeast supplement on celecoxib plasma levels: a randomized phase II trial 2004 · celecoxib plus selenized baker's yeast group · Healthy adults aged 40–75 years | 200 mcg | 4 weeks | — |
| Suppression of human immunodeficiency virus type 1 viral load with selenium supplementation: a randomized controlled trial 2007 · selenium-treated group · Adult men and women with HIV-1 infection | 200 mcg | 274 days | — |
| Effect of long-term selenium yeast intervention on activity and gene expression of antioxidant and xenobiotic metabolising enzymes in healthy elderly volunteers from the Danish Prevention of Cancer by Intervention by Selenium (PRECISE) pilot study 2008 · 200 microg Se as Se-enriched yeast · Healthy elderly Danish volunteers; mean age 71.3 years; men and women | 200 mcg | 5 years | — |
| Effect of selenium supplements on hemoglobin concentration and morbidity among HIV-1-infected Tanzanian women 2009 · selenium supplement group · Adult pregnant women with HIV-1 infection in Tanzania; mean age 27.7 years | 200 mcg | 283 days | — |
| Effect of L-arginine and selenium added to a hypocaloric diet enriched with legumes on cardiovascular disease risk factors in women with central obesity: a randomized, double-blind, placebo-controlled trial 2012 · Selenium and HDEL · Premenopausal women with central obesity | 200 mcg | 6 weeks | — |
| Selenium deficiency occurs in some patients with moderate-to-severe cirrhosis and can be corrected by administration of selenate but not selenomethionine: a randomized controlled trial 2015 · selenate 200 μg/d · Patients with Child-Pugh classes A, B, and C cirrhosis | 200 mcg | 4 weeks | — |
| Selenium deficiency occurs in some patients with moderate-to-severe cirrhosis and can be corrected by administration of selenate but not selenomethionine: a randomized controlled trial 2015 · selenomethionine 200 μg/d · Patients with Child-Pugh classes A, B, and C cirrhosis | 200 mcg | 4 weeks | — |
| Effect of long-term vitamin E and selenium supplementation on urine F2-isoprostanes, a biomarker of oxidative stress 2016 · selenium · men aged 55 years or older (50 or older for African Americans) who were current smokers without COPD | 200 mcg | 3 years | — |
| l-selenomethionine supplementation in children and adolescents with autoimmune thyroiditis: A randomized double-blind placebo-controlled clinical trial 2019 · l-selenomethionine group · Children and adolescents aged 4.5–17.8 years with autoimmune thyroiditis | 200 mcg | 26 weeks | — |
| The effect of selenium and zinc on CD4(+) count and opportunistic infections in HIV/AIDS patients: a randomized double blind trial 2020 · selenium · HIV-positive patients receiving combination antiretroviral therapy with CD4(+) count above 200 per cubic millimeter | 200 mcg | 26 weeks | — |
| Effects of Selenium Supplementation on Asymmetric Dimethylarginine and Cardiometabolic Risk Factors in Patients with Polycystic Ovary Syndrome 2020 · selenium group · Women aged 18–45 years with polycystic ovary syndrome | 200 mcg | 12 weeks | — |
| Sodium selenite and Se-enriched yeast supplementation in atherosclerotic patients: Effects on the expression of pyroptosis-related genes and oxidative stress status 2022 · sodium selenite · Patients with atherosclerosis; age and sex not reported | 200 mcg | 8 weeks | — |
| Sodium selenite and Se-enriched yeast supplementation in atherosclerotic patients: Effects on the expression of pyroptosis-related genes and oxidative stress status 2022 · Se-enriched yeast · Patients with atherosclerosis; age and sex not reported | 200 mcg | 8 weeks | — |
| Effects of Selenium and/or N-Acetyl-Cysteine Supplementation on Nonthyroidal Illness Syndrome in Hemodialysis Patients: A Factorial Randomized Controlled Trial 2022 · group C · Hemodialysis patients with nonthyroidal illness syndrome; age and sex not specified | 200 mcg | 12 weeks | — |
| The effects of selenium supplementation on glycemic control, serum lipoproteins and biomarkers of oxidative stress in infertile women diagnosed with polycystic ovary syndrome undergoing in vitro fertilization: A randomized, double-blind, placebo-controlled trial 2022 · selenium supplements · Infertile women aged 18–40 years with polycystic ovary syndrome undergoing IVF | 200 mcg | 8 weeks | — |
| Supplementation with selenium and human immune cell functions. I. Effect on lymphocyte proliferation and interleukin 2 receptor expression 1994 · Selenium-supplemented humans · Selenium-replete humans; age and sex not stated | 200 mcg | 8 weeks | — |
| Supplementation with selenium and human immune cell functions. II. Effect on cytotoxic lymphocytes and natural killer cells 1994 · selenium · Selenium-replete human participants; age and sex not specified | 200 mcg | 8 weeks | — |
| Long-term supplementation with selenate and selenomethionine: selenium and glutathione peroxidase (EC 1.11.1.9) in blood components of New Zealand women 1993 · Se-enriched yeast (selenomethionine) · Women aged 18–23 years; the paper describes their dietary selenium intake as insufficient to meet recommended intakes and their status as potentially marginal. | 200 mcg | 32 weeks | — |
| Long-term supplementation with selenate and selenomethionine: selenium and glutathione peroxidase (EC 1.11.1.9) in blood components of New Zealand women 1993 · Brewer's yeast mixed with selenate · Women aged 18–23 years; the paper describes their dietary selenium intake as insufficient to meet recommended intakes and their status as potentially marginal. | 200 mcg | 32 weeks | — |
| Increase in insulin-like growth factor 1 (IGF-1) and insulin-like growth factor binding protein 1 after supplementation with selenium and coenzyme Q10. A prospective randomized double-blind placebo-controlled trial among elderly Swedish citizens 2017 · active treatment · Elderly healthy Swedish adults, mean age about 76 years; both sexes; some had hypertension, ischemic heart disease, or diabetes | 200 mcg | 1461 days | 117 |
| Associations between glutathione peroxidase-1 Pro198Leu polymorphism, selenium status, and DNA damage levels in obese women after consumption of Brazil nuts 2011 · Brazil nut supplementation · Morbidly obese women who were selenium deficient at baseline; ages not reported | 290 mcg | 8 weeks | 37 |
| Enzymatic and non-enzymatic antioxidant status in stage (III) human oral squamous cell carcinoma and treated with radical radio therapy: influence of selenium supplementation 2006 · Group D · Patients with stage III oral squamous cell carcinoma receiving radiotherapy; age and sex not reported | 400 mcg | 26 weeks | 36 |
| Intake of partially defatted Brazil nut flour reduces serum cholesterol in hypercholesterolemic patients--a randomized controlled trial 2015 · diet + partially defatted Brazil nut flour · Men and women aged 40–80 with dyslipidemia and hypertension, receiving medication for both conditions and diagnosed with euthyroidism | 228 mcg | 90 days | 35 |
| Dose-dependent effects of selenized yeast on total selenium levels in prostatic tissue of men with prostate cancer 2011 · 400 μg selenized yeast group · Men under 80 with biopsy-proven, non-metastatic prostate adenocarcinoma undergoing radical prostatectomy | 400 mcg | 6 weeks | 17 |
| Association of selenium status and blood glutathione concentrations in blacks and whites 2011 · selenium arm · Healthy men aged 19–43 years | 247 mcg | 39 weeks | 17 |
| Low selenium status in alcoholic cirrhosis is correlated with aminopyrine breath test. Preliminary effects of selenium supplementation 1995 · selenium-supplemented group · Hospitalized patients with severe alcoholic cirrhosis; age and sex not reported | 100 mcg | 120 days | 4 |
| Influence of selenium-enriched yeast supplementation on biomarkers of oxidative damage and hormone status in healthy adult males: a clinical pilot study 2002 · selenium group · Healthy adult males aged 19–43 years | 247 mcg | 270 days | — |
| An increase in selenium intake improves immune function and poliovirus handling in adults with marginal selenium status 2004 · 100 microg Se group · Adults in the United Kingdom with relatively low plasma selenium concentrations (<1.2 micromol/L) | 100 mcg | 15 weeks | — |
| Supplementation with wheat selenium induces a dose-dependent response in serum and urine of a Se-replete population 1992 · 100 micrograms Se daily · Healthy Norwegian women; age not reported | 100 mcg | 6 weeks | — |
| Supplementation with wheat selenium induces a dose-dependent response in serum and urine of a Se-replete population 1992 · 300 micrograms Se daily · Healthy Norwegian women; age not reported | 300 mcg | 6 weeks | — |
| Response of selenium status indicators to supplementation of healthy North American men with high-selenium yeast 2008 · high-selenium yeast supplementation · free-living healthy North American men | 300 mcg | 48 weeks | — |
| Brazil nuts: an effective way to improve selenium status 2008 · Selenomethionine group · New Zealand adults; age, sex, and health condition not specified | 100 mcg | 12 weeks | — |
| Effect of various levels of selenium in wheat and meat on blood Se status indices and on Se balance in Dutch men 1991 · 135 micrograms Se/d as Se-rich meat · Dutch men after a 5-week period of low selenium intake | 135 mcg | 9 weeks | — |
| Effect of various levels of selenium in wheat and meat on blood Se status indices and on Se balance in Dutch men 1991 · 135 micrograms Se/d as Se-rich bread · Dutch men after a 5-week period of low selenium intake | 135 mcg | 9 weeks | — |
| Effect of various levels of selenium in wheat and meat on blood Se status indices and on Se balance in Dutch men 1991 · 215 micrograms Se/d as Se-rich meat · Dutch men after a 5-week period of low selenium intake | 215 mcg | 9 weeks | — |
| Effect of various levels of selenium in wheat and meat on blood Se status indices and on Se balance in Dutch men 1991 · 215 micrograms Se/d as Se-rich bread · Dutch men after a 5-week period of low selenium intake | 215 mcg | 9 weeks | — |
| Establishing optimal selenium status: results of a randomized, double-blind, placebo-controlled trial 2010 · 100 microg Se-yeast group · Healthy men and women aged 50–64 years | 100 mcg | 12 weeks | — |
| The influence of selenium-enriched milk proteins and selenium yeast on plasma selenium levels and rectal selenoprotein gene expression in human subjects 2011 · dairy-Se · Healthy volunteers with plasma selenium in the lower half of the population range | 150 mcg | 6 weeks | — |
| The influence of selenium-enriched milk proteins and selenium yeast on plasma selenium levels and rectal selenoprotein gene expression in human subjects 2011 · yeast-Se · Healthy volunteers with plasma selenium in the lower half of the population range | 150 mcg | 6 weeks | — |
| Differential responses to selenomethionine supplementation by sex and genotype in healthy adults 2012 · 100 μg/d as L-SeMet · Healthy American adults; men and women | 100 mcg | 1 year | — |
| Comparative effects of two different forms of selenium on oxidative stress biomarkers in healthy men: a randomized clinical trial 2014 · high dose SY (SY285) · Healthy nonsmoking men aged 20–79 years; analyzed participants were aged 23–78 years and had no chronic disease | 285 mcg | 39 weeks | — |
| Selenoprotein P increases upon selenium and coenzyme Q(10) supplementation and is associated with telomere length, quality of life and reduced inflammation and mortality 2024 · selenium yeast and coenzyme Q 10 supplementation · elderly community-living participants with low selenium status | 200 mcg | 4 years | — |
| Selenium supplementation in intrinsic asthma 1993 · Se-supplemented group · Patients with intrinsic asthma; age and sex not reported | 100 mcg | 14 weeks | — |
| Supplementary selenium influences the response to fatty acid-induced oxidative stress in humans 1997 · Group 3 · Women, mean age 23.5 years; no specific condition stated | 115 mcg | 6 weeks | — |
| Levels of sP-selectin and hs-CRP Decrease with Dietary Intervention with Selenium and Coenzyme Q10 Combined: A Secondary Analysis of a Randomized Clinical Trial 2015 · Active treatment · Adults aged 70–88 years from an elderly Swedish community population; no condition required for inclusion | 200 mcg | 1461 days | 221 |
| Significant Changes in Metabolic Profiles after Intervention with Selenium and Coenzyme Q10 in an Elderly Population 2019 · SeQ10 active treatment group · Men aged 70–88 from a healthy elderly community-living population | 200 mcg | 4 years | 221 |
| Effects of an Intervention with Selenium and Coenzyme Q(10) on Five Selected Age-Related Biomarkers in Elderly Swedes Low in Selenium: Results That Point to an Anti-Ageing Effect-A Sub-Analysis of a Previous Prospective Double-Blind Placebo-Controlled Randomised Clinical Trial 2023 · Active treatment · Elderly community-dwelling Swedes with low selenium status; age range not stated at intervention | 200 mcg | 1461 days | 220 |
| Influence of the glutathione peroxidase 1 Pro200Leu polymorphism on the response of glutathione peroxidase activity to selenium supplementation: a randomized controlled trial 2012 · selenium supplement · People with coronary artery disease in New Zealand | 100 mcg | 12 weeks | 129 |
| Effect of supplementation with high-selenium yeast on plasma lipids: a randomized trial 2011 · 100 mcg/d selenium · Volunteers aged 60 to 74 years | 100 mcg | 26 weeks | 127 |
| Effect of supplementation with high-selenium yeast on plasma lipids: a randomized trial 2011 · 300 mcg/d selenium · Volunteers aged 60 to 74 years | 300 mcg | 26 weeks | 126 |
| Does selenium supplementation affect thyroid function? Results from a randomized, controlled, double-blinded trial in a Danish population 2015 · 100 μg selenium-enriched yeast · Males and females aged 60–74 years with suboptimal dietary selenium intake | 100 mcg | 5 years | 124 |
| Does selenium supplementation affect thyroid function? Results from a randomized, controlled, double-blinded trial in a Danish population 2015 · 300 μg selenium-enriched yeast · Males and females aged 60–74 years with suboptimal dietary selenium intake | 300 mcg | 5 years | 119 |
| Decreased Concentration of Fibroblast Growth Factor 23 (FGF-23) as a Result of Supplementation with Selenium and Coenzyme Q(10) in an Elderly Swedish Population: A Sub-Analysis 2022 · active treatment group · Swedish adults aged 70–88 with low selenium status | 200 mcg | 1461 days | 118 |
| Selenium and Coenzyme Q10 Supplementation Improves Renal Function in Elderly Deficient in Selenium: Observational Results and Results from a Subgroup Analysis of a Prospective Randomised Double-Blind Placebo-Controlled Trial 2020 · Active supplementation with selenium and coenzyme Q10 · Adults aged 70–88 years with low pre-intervention selenium status, living in the community | 200 mcg | 1461 days | 117 |
| Dietary Supplementation with Selenium and Coenzyme Q(10) Prevents Increase in Plasma D-Dimer While Lowering Cardiovascular Mortality in an Elderly Swedish Population 2021 · Active treatment · Adults aged 70–88 years living in a Swedish rural community, with suboptimal serum selenium status; the analysed group excluded people with atrial fibrillation or anticoagulant treatment, malignancy, or left atrium dimension over 40 mm. | 200 mcg | 4 years | 106 |
| Prooxidant-antioxidant balance in pregnancy: a randomized double-blind placebo-controlled trial of selenium supplementation 2010 · selenium group · Primigravid pregnant women in the first trimester | 100 mcg | — | 83 |
| Selenium and Coenzyme Q(10) Intervention Prevents Telomere Attrition, with Association to Reduced Cardiovascular Mortality-Sub-Study of a Randomized Clinical Trial 2022 · active treatment · Adults aged over 69 years living in a rural municipality in Sweden, with low selenium status; elderly population | 200 mcg | 4 years | 67 |
| Organic selenium supplementation increases mercury excretion and decreases oxidative damage in long-term mercury-exposed residents from Wanshan, China 2012 · selenium-enriched yeast group · Long-term mercury-exposed residents from Wanshan, China | 100 mcg | 90 days | 53 |
| Selenium supplementation in patients undergoing hematopoietic stem cell transplantation: effects on pro-inflammatory cytokines levels 2014 · Selenium group · Adults aged 18–55 with AML or ALL undergoing allogeneic hematopoietic stem cell transplantation | 400 mcg | 3 weeks | 37 |
| Effects of selenium and zinc supplementation on nutritional status in patients with cancer of digestive tract 2001 · selenium and zinc treated group · Adults with digestive tract cancer receiving chemotherapy; median age 55 years (range 46–61) | 200 mcg | 50 days | 30 |
| Significant changes in circulating microRNA by dietary supplementation of selenium and coenzyme Q10 in healthy elderly males. A subgroup analysis of a prospective randomized double-blind placebo-controlled trial among elderly Swedish citizens 2017 · Active treatment · Men aged 70–80 years in a community-based elderly population; some had hypertension or ischemic heart disease, and many had low selenium status | 200 mcg | 4 years | 25 |
| Effects of selenium supplementation on selenoprotein gene expression and response to influenza vaccine challenge: a randomised controlled trial 2011 · 100 µg/day Se-yeast · Men and women aged 50–64 with suboptimal selenium status (plasma selenium <110 ng/ml) | 100 mcg | 12 weeks | 21 |
| [Diabetes mellitus--a free radical-associated disease. Results of adjuvant antioxidant supplementation] 1993 · selenium group · Patients with diabetes mellitus and long-term diabetic late syndrome; age and sex not reported | 100 mcg | 90 days | 20 |
| Effects of Zinc and Selenium Supplementation on Thyroid Function in Overweight and Obese Hypothyroid Female Patients: A Randomized Double-Blind Controlled Trial 2015 · Zn + Se (ZS) · Overweight or obese female patients with hypothyroidism | 200 mcg | 12 weeks | 17 |
| A short-term intervention with selenium affects expression of genes implicated in the epithelial-to-mesenchymal transition in the prostate 2017 · selenium group · Men at high risk for prostate cancer or diagnosed with prostate cancer or high-grade prostatic intraepithelial neoplasia; ages approximately 61–73 years | 300 mcg | 5 weeks | 12 |
| Muscle GSH-Px activity after prolonged exercise, training, and selenium supplementation 1995 · Sel group · Healthy, nonsmoking males, mean age 22.9 years | 240 mcg | 10 weeks | 12 |
| Effect of the antioxidants selenium and beta-carotene on HIV-related endothelium dysfunction 1998 · selenium · HIV-seropositive subjects | 100 mcg | 1 year | 10 |
| Studies regarding the antioxidant effects of selenium on top swimmers 1990 · 14-day selenium group · Top swimmers; 9 participants in this treatment group, with age and sex breakdown not reported | 100 mcg | 2 weeks | 9 |
| Methyl selenocysteine: single-dose pharmacokinetics in men 2011 · 400 mcg MSC group · Healthy men aged 18 or older | 400 mcg | 1 day | 5 |
| The retention and distribution by healthy young men of stable isotopes of selenium consumed as selenite, selenate or hydroponically-grown broccoli are dependent on the isotopic form 1999 · High-selenium diet · Healthy young men | 227 mcg | 15 weeks | — |
| Effect of long-term selenium yeast intervention on activity and gene expression of antioxidant and xenobiotic metabolising enzymes in healthy elderly volunteers from the Danish Prevention of Cancer by Intervention by Selenium (PRECISE) pilot study 2008 · 100 microg Se as Se-enriched yeast · Healthy elderly Danish volunteers; mean age 71.3 years; men and women | 100 mcg | 5 years | — |
| Effect of long-term selenium yeast intervention on activity and gene expression of antioxidant and xenobiotic metabolising enzymes in healthy elderly volunteers from the Danish Prevention of Cancer by Intervention by Selenium (PRECISE) pilot study 2008 · 300 microg Se as Se-enriched yeast · Healthy elderly Danish volunteers; mean age 71.3 years; men and women | 300 mcg | 5 years | — |
| Functional effects of a common single-nucleotide polymorphism (GPX4c718t) in the glutathione peroxidase 4 gene: interaction with sex 2008 · CC genotype · Individuals of both sexes with the CC genotype for the GPX4c718t SNP; age and health status not stated | 100 mcg | 6 weeks | — |
| Functional effects of a common single-nucleotide polymorphism (GPX4c718t) in the glutathione peroxidase 4 gene: interaction with sex 2008 · TT genotype · Individuals of both sexes with the TT genotype for the GPX4c718t SNP; age and health status not stated | 100 mcg | 6 weeks | — |
| Selenium and iodine supplementation: effect on thyroid function of older New Zealanders 2009 · selenium · Adults aged 60–80 years; older Dunedin volunteers with marginal selenium status and mild iodine deficiency | 100 mcg | 90 days | — |
| Studies regarding the antioxidant effects of selenium on top swimmers 1990 · single-dose selenium group · Top swimmers; 16 girls and 17 boys across the trial, with ages and individual arm counts not reported | 150 mcg | 1 day | — |
| Selenium deficiency occurs in some patients with moderate-to-severe cirrhosis and can be corrected by administration of selenate but not selenomethionine: a randomized controlled trial 2015 · selenate 400 μg/d · Patients with Child-Pugh classes A, B, and C cirrhosis | 400 mcg | 4 weeks | — |
| Selenium and coenzyme Q(10) improve the systemic redox status while reducing cardiovascular mortality in elderly population-based individuals 2023 · selenium and coenzyme Q10 supplementation · Elderly community-dwelling individuals with low levels of selenium and coenzyme Q10 | 200 mcg | 4 years | — |
| A Multicountry Analysis of Maternal Selenium Status in Pregnancy and Lactation and Infant Birth Outcomes: Findings from the Women First Maternal Preconception Study 2026 · Arm 2 (sqLNS starting at approximately 12 weeks of gestation) · Women intending to become pregnant within a year, recruited from Guatemala, India, and Pakistan; pregnancy and lactation | 130 mcg | — | 348 |
| A Multicountry Analysis of Maternal Selenium Status in Pregnancy and Lactation and Infant Birth Outcomes: Findings from the Women First Maternal Preconception Study 2026 · Arm 1 (sqLNS starting at least 3 months prior to conception) · Women intending to become pregnant within a year, recruited from Guatemala, India, and Pakistan; pregnancy and lactation | 130 mcg | — | 331 |
| Genetic polymorphisms that affect selenium status and response to selenium supplementation in United Kingdom pregnant women 2016 · selenium group · Primiparous pregnant women in the United Kingdom; age 18 years or older | 60 mcg | — | 113 |
| Enteral yeast-selenium supplementation in preterm infants 1998 · supplemented group · Preterm infants in a low-selenium area of Hungary | 5 mcg | 2 weeks | 18 |
| A report of high-dose selenium supplementation: response and toxicities 2004 · 3200 microg/day group · Men with biopsy-proven prostate cancer | 3.2 mg | 1 year | 16 |
| Selenium absorption and retention from a selenite- or selenate-fortified milk-based formula in men measured by a stable-isotope technique 2001 · SeO3(2−) (selenite) · Healthy men; age not stated | 40 mcg | 2 days | 10 |
| Selenium absorption and retention from a selenite- or selenate-fortified milk-based formula in men measured by a stable-isotope technique 2001 · SeO4(2−) (selenate) · Healthy men; age not stated | 40 mcg | 2 days | 10 |
| Selenium fortification of an Italian rice cultivar via foliar fertilization with sodium selenate and its effects on human serum selenium levels and on erythrocyte glutathione peroxidase activity 2014 · intervention group · Healthy young women, mean age 25 ± 2 years | 80 g | 20 days | 10 |
| Supplementation with Brazil nuts and green tea extract regulates targeted biomarkers related to colorectal cancer risk in humans 2016 · Se (Brazil nuts) · Volunteers over 50 years of age with plasma selenium ≤1.36 µmol/L | 48 mcg | — | 9 |
| A report of high-dose selenium supplementation: response and toxicities 2004 · 1600 microg/day group · Men with biopsy-proven prostate cancer | 1.6 mg | 1 year | 8 |
| An increase in selenium intake improves immune function and poliovirus handling in adults with marginal selenium status 2004 · 50 microg Se group · Adults in the United Kingdom with relatively low plasma selenium concentrations (<1.2 micromol/L) | 50 mcg | 15 weeks | — |
| Effectiveness of selenium supplements in a low-selenium area of China 2005 · Selenomethionine · Selenium-deficient subjects in China; ages and sex not stated | 37 mcg | 20 weeks | — |
| Effectiveness of selenium supplements in a low-selenium area of China 2005 · Selenite · Selenium-deficient subjects in China; ages and sex not stated | 66 mcg | 20 weeks | — |
| Selenium absorption and retention by very-low-birth-weight infants: studies with the extrinsic stable isotope tag 74Se 1991 · standard premature formula · Premature infants with birth weights 720–1,630 g and gestational ages 26–33 weeks | 0.00103 mg/kg | 1 day | — |
| Effect of various levels of selenium in wheat and meat on blood Se status indices and on Se balance in Dutch men 1991 · 55 micrograms Se/d as Se-rich meat · Dutch men after a 5-week period of low selenium intake | 55 mcg | 9 weeks | — |
| Effect of various levels of selenium in wheat and meat on blood Se status indices and on Se balance in Dutch men 1991 · 55 micrograms Se/d as Se-rich bread · Dutch men after a 5-week period of low selenium intake | 55 mcg | 9 weeks | — |
| Establishing optimal selenium status: results of a randomized, double-blind, placebo-controlled trial 2010 · 50 microg Se-yeast group · Healthy men and women aged 50–64 years | 50 mcg | 12 weeks | — |
| Establishing optimal selenium status: results of a randomized, double-blind, placebo-controlled trial 2010 · Selenium-enriched onion meals group · Healthy men and women aged 50–64 years | 50 mcg | 12 weeks | — |
| Differential responses to selenomethionine supplementation by sex and genotype in healthy adults 2012 · 50 μg/d as L-SeMet · Healthy American adults; men and women | 50 mcg | 1 year | — |
| Supranutritional Sodium Selenate Supplementation Delivers Selenium to the Central Nervous System: Results from a Randomized Controlled Pilot Trial in Alzheimer's Disease 2019 · supranutritional group · Patients with Alzheimer's disease; age and sex not stated | 30 mg | 24 weeks | — |
| Improving the selenium supply of vegans and omnivores with Brazil nut butter compared to a dietary supplement in a randomized controlled trial 2025 · Selenium supplement group — vegans · Vegans aged 19–32 years; apparently healthy adults without acute or chronic disease and without baseline serum selenium above 150 µg/L | 55 mcg | 2 weeks | — |
| Improving the selenium supply of vegans and omnivores with Brazil nut butter compared to a dietary supplement in a randomized controlled trial 2025 · Selenium supplement group — omnivores · Omnivores aged 19–32 years; apparently healthy adults without acute or chronic disease and without baseline serum selenium above 150 µg/L | 55 mcg | 2 weeks | — |
| Effect of double-blind crossover selenium supplementation on biological indices of selenium status in cystic fibrosis patients 1993 · selenium supplementation · Patients with cystic fibrosis | 0.0028 mg/kg | 150 days | — |
| Effect of 6 month supplementation with different combinations of an association of antioxidant nutrients on biochemical parameters and markers of the antioxidant defence system in the elderly. The Geriatrie/Min.Vit.Aox Network 1996 · T (trace elements) · Elderly nursing-home residents aged 65–103 years who were long-term hospitalized | 100 mcg | 26 weeks | — |
| Effect of a two-year supplementation with low doses of antioxidant vitamins and/or minerals in elderly subjects on levels of nutrients and antioxidant defense parameters 1997 · mineral group · Hospitalized adults older than 65 years; baseline deficiencies of zinc and selenium were common | 100 mcg | 2 years | — |
| Supplementary selenium influences the response to fatty acid-induced oxidative stress in humans 1997 · Group 2 · Women, mean age 23.5 years; no specific condition stated | 115 mcg | 6 weeks | — |
| Effect of low-dose selenium on thyroid autoimmunity and thyroid function in UK pregnant women with mild-to-moderate iodine deficiency 2016 · Se group · Women in their first pregnancy, recruited at 12–14 weeks’ gestation, with mild-to-moderate iodine deficiency | 60 mcg | — | 115 |
| Selenium supplementation could restore euthyroidism in subclinical hypothyroid patients with autoimmune thyroiditis 2016 · case · Patients with autoimmune thyroiditis and mild subclinical hypothyroidism (TSH < 10 mU/L) | 83 mcg | 120 days | 96 |
| A pilot study on the beneficial effects of additional selenium supplementation to methimazole for treating patients with Graves’ disease 2019 · MMI + Se group · Adults with newly diagnosed hyperthyroidism meeting Graves’ disease diagnostic criteria; age 18 or older, men and women | 600 mcg | 180 days | 45 |
| Sperm oxidative stress and the effect of an oral vitamin E and selenium supplement on semen quality in infertile men 2003 · Vitamin E and selenium · Infertile men | 225 mcg | 90 days | 28 |
| Selenium supplementation decreases nuclear factor-kappa B activity in peripheral blood mononuclear cells from type 2 diabetic patients 2004 · selenium supplementation · Adults with type 2 diabetes | 960 mcg | 90 days | 21 |
| Effects of selenium supplementation on selenoprotein gene expression and response to influenza vaccine challenge: a randomised controlled trial 2011 · 50 µg/day Se-yeast · Men and women aged 50–64 with suboptimal selenium status (plasma selenium <110 ng/ml) | 50 mcg | 12 weeks | 18 |
| Effects of selenium supplementation on selenoprotein gene expression and response to influenza vaccine challenge: a randomised controlled trial 2011 · Se-enriched onions 50 µg/day · Men and women aged 50–64 with suboptimal selenium status (plasma selenium <110 ng/ml) | 50 mcg | 12 weeks | 18 |
| Methyl selenocysteine: single-dose pharmacokinetics in men 2011 · 800 mcg MSC group · Healthy men aged 18 or older | 800 mcg | 1 day | 5 |
| Methyl selenocysteine: single-dose pharmacokinetics in men 2011 · 1200 mcg MSC group · Healthy men aged 18 or older | 1.2 mg | 1 day | 5 |
| The retention and distribution by healthy young men of stable isotopes of selenium consumed as selenite, selenate or hydroponically-grown broccoli are dependent on the isotopic form 1999 · Low-selenium diet · Healthy young men | 32.6 mcg | 15 weeks | — |
| An estimation of selenium requirements for New Zealanders 1999 · 10 microgram Se group · Adults with low blood selenium concentrations | 10 mcg | 20 weeks | — |
| An estimation of selenium requirements for New Zealanders 1999 · 20 microgram Se group · Adults with low blood selenium concentrations | 20 mcg | 20 weeks | — |
| An estimation of selenium requirements for New Zealanders 1999 · 30 microgram Se group · Adults with low blood selenium concentrations | 30 mcg | 20 weeks | — |
| An estimation of selenium requirements for New Zealanders 1999 · 40 microgram Se group · Adults with low blood selenium concentrations | 40 mcg | 20 weeks | — |
| Effects of organic and inorganic selenium supplementation on selenoenzyme activity in blood lymphocytes, granulocytes, platelets and erythrocytes 2000 · Selenomethionine-treated subjects · Healthy men and women from a U.K. population; ages not stated | 50 mcg | 4 weeks | — |
| Effects of organic and inorganic selenium supplementation on selenoenzyme activity in blood lymphocytes, granulocytes, platelets and erythrocytes 2000 · Sodium selenite-treated subjects · Healthy men and women from a U.K. population; ages not stated | 50 mcg | 4 weeks | — |
| Influence of selenium supplements on the post-traumatic alterations of the thyroid axis: a placebo-controlled trial 2001 · Selenium · Critically ill trauma patients, mean age 42 years, with severe multiple injury | 500 mcg | 5 days | — |
| Consumption of Brazil nuts with high selenium levels increased inflammation biomarkers in obese women: A randomized controlled trial 2019 · Brazil nut group (BN) · Women with obesity | 1.26 mg | 60 days | — |
| Selenium supplementation in the management of thyroid autoimmunity during pregnancy: results of the "SERENA study", a randomized, double-blind, placebo-controlled trial 2019 · L-selenomethionine (L-Se-Met) · Pregnant women with thyroiditis | 83 mcg | — | — |
| Food as medicine: Selenium enriched lentils offer relief against chronic arsenic poisoning in Bangladesh 2019 · Se-group · Participants in Bangladesh chronically exposed to arsenic | 55 mcg | 26 weeks | — |
| Derepression of glomerular filtration, renal blood flow and antioxidant defence in patients with type 2 diabetes at high-risk of cardiorenal disease 2020 · selenium · Adults with type 2 diabetes and hypertension and/or microalbuminuria, eGFR >45 mL/min/1.73 m²; non-Caucasian or Caucasian | 20 mcg | 1 year | — |
| Including 60 mg Elemental Iron in a Multiple Micronutrient Supplement Blunts the Increase in Serum Zinc after 12 Weeks of Daily Supplementation in Predominantly Anemic, Nonpregnant Cambodian Women of Reproductive Age 2019 · MMN · Predominantly anemic, nonpregnant women aged 18–45 years | 65 mcg | 12 weeks | 202 |
| Multicenter, phase 3 trial comparing selenium supplementation with observation in gynecologic radiation oncology 2010 · selenium group (SG) · Patients with cervical or uterine cancer and initial selenium concentrations below 84 μg/L receiving radiotherapy | 800 mcg | — | 39 |
| Supplementation with Brazil nuts and green tea extract regulates targeted biomarkers related to colorectal cancer risk in humans 2016 · Combination of Brazil nuts and green tea extract · Volunteers over 50 years of age with plasma selenium ≤1.36 µmol/L | 48 mcg | — | 12 |
| Selenium absorption and retention by very-low-birth-weight infants: studies with the extrinsic stable isotope tag 74Se 1991 · selenium-supplemented premature formula · Premature infants with birth weights 720–1,630 g and gestational ages 26–33 weeks | 0.00103 mg/kg | 1 day | — |
| Minimal impact of excess iodate intake on thyroid hormones and selenium status in older New Zealanders 2011 · Se+highI · Older adults, mean age 73±4.8 years; sex and health condition not specified | 100 mcg | 8 weeks | — |
| [Selenium concentration in erythrocytes of patients with rheumatoid arthritis. Clinical and laboratory chemistry infection markers during administration of selenium] 1997 · Selenium-supplemented group · Adults with rheumatoid arthritis | 200 mcg | 90 days | — |
| Effects of Souvenaid on plasma micronutrient levels and fatty acid profiles in mild and mild-to-moderate Alzheimer's disease 2015 · Active group (RCT1, RCT2 and RCT3) · Men and women aged 50 years or older with mild or mild-to-moderate Alzheimer's disease; RCT3 participants were on stable approved Alzheimer's medication, while RCT1 and RCT2 participants were drug-free for Alzheimer's medication. | 60 mcg | 24 weeks | 501 |
| Effect of selenium supplementation on HIV-1 RNA detection in breast milk of Tanzanian women 2014 · selenium group · HIV-infected pregnant women enrolled at 12–27 weeks of gestation and followed postpartum | 200 mcg | — | 209 |
| Including 60 mg Elemental Iron in a Multiple Micronutrient Supplement Blunts the Increase in Serum Zinc after 12 Weeks of Daily Supplementation in Predominantly Anemic, Nonpregnant Cambodian Women of Reproductive Age 2019 · Fe + MMN · Predominantly anemic, nonpregnant women aged 18–45 years | 65 mcg | 12 weeks | 206 |
| Effects of Souvenaid on plasma micronutrient levels and fatty acid profiles in mild and mild-to-moderate Alzheimer's disease 2015 · Active product during open-label extension (OLE) · Men and women aged 50 years or older with mild Alzheimer's disease who completed RCT2. | 60 mcg | 24 weeks | 201 |
| Effects of Multivitamin, Multimineral and Phytonutrient Supplementation on Nutrient Status and Biomarkers of Heart Health Risk in a Russian Population: A Randomized, Double Blind, Placebo Controlled Study 2018 · VMP (Nutrilite Double X™) · Generally healthy adults aged 40–70 years in Moscow with low habitual recommended-food intake (recommended food score <12), predominantly women; no chronic diseases | 50 mcg | 8 weeks | 60 |
| Trace element supplementation in hemodialysis patients: a randomized controlled trial 2015 · medium dose · Adults aged 18 years or older on maintenance hemodialysis, with end-stage kidney disease | 75 mcg | 180 days | 52 |
| Trace element supplementation in hemodialysis patients: a randomized controlled trial 2015 · low dose · Adults aged 18 years or older on maintenance hemodialysis, with end-stage kidney disease | 50 mcg | 180 days | 47 |
| Coenzyme Q10 and antioxidants in acute myocardial infarction 1994 · verum group · Patients admitted with acute myocardial infarction and symptom duration under 6 hours | 600 mcg | 1 year | 32 |
| The effects of probiotic and selenium co-supplementation on parameters of mental health, hormonal profiles, and biomarkers of inflammation and oxidative stress in women with polycystic ovary syndrome 2018 · Probiotic plus selenium group · Women aged 18–40 with polycystic ovary syndrome (PCOS) | 200 mcg | 12 weeks | 30 |
| The effects of selenium plus probiotics supplementation on glycemic status and serum lipoproteins in patients with gestational diabetes mellitus: A randomized, double-blind, placebo-controlled trial 2022 · Probiotic plus selenium · Pregnant women with gestational diabetes mellitus | 200 mcg | 6 weeks | 30 |
| Add-On Effect of Selenium and Vitamin D Combined Supplementation in Early Control of Graves' Disease Hyperthyroidism During Methimazole Treatment 2022 · MMI+Se+VitD (intervention group) · Adults aged 18–70 with newly diagnosed Graves’ disease and low or suboptimal selenium and vitamin D levels | 100 mcg | 270 days | 21 |
| Antioxidant therapy for recurrent pancreatitis: biochemical profiles in a placebo-controlled trial 1992 · active treatment · Patients with recurrent non-gallstone pancreatitis | 600 mcg | 10 weeks | 20 |
| One-year application of probiotic strain Enterococcus faecium M-74 decreases serum cholesterol levels 2005 · E-group · Older adult volunteers; mean age 75.4 years | 50 mcg | 56 weeks | 20 |
| Sodium selenite and N-acetylcysteine in antiretroviral-naive HIV-1-infected patients: a randomized, controlled pilot study 1998 · Group A · Antiretroviral-naive adults with HIV infection at CDC'93 stages I and II | 500 mcg | 24 weeks | 13 |
| Sodium selenite and N-acetylcysteine in antiretroviral-naive HIV-1-infected patients: a randomized, controlled pilot study 1998 · Group B · Antiretroviral-naive adults with HIV infection at CDC'93 stages I and II | 500 mcg | 12 weeks | 11 |
| High-dose supplementation of selenium in left ventricular assist device implant surgery: A double-blinded, randomized controlled pilot trial 2022 · Selenium intervention group · Patients with heart failure scheduled for left ventricular assist device implantation; age and sex not reported. | 300 mcg | 2 weeks | 10 |
| Combined antioxidant treatment effects on blood oxidative stress after eccentric exercise 2005 · antioxidant supplement · Women aged 19–31 years who were not resistance-trained, undergoing eccentric elbow-flexor exercise | 90 mcg | 16 days | 9 |
| Influence of selenium supplements on the post-traumatic alterations of the thyroid axis: a placebo-controlled trial 2001 · Selenium with alpha-tocopherol and zinc · Critically ill trauma patients, mean age 42 years, with severe multiple injury | 500 mcg | 5 days | — |
| Effect of two years' supplementation with natural antioxidants on vitamin and trace element status biomarkers: preliminary data of the SU.VI.MAX study 2001 · Antioxidant supplementation group · Women aged 35–60 years and men aged 45–60 years in France, general population | 100 mcg | 2 years | — |
| Improved antioxidant and fatty acid status of patients with cystic fibrosis after antioxidant supplementation is linked to improved lung function 2003 · group B [high dose of supplement] · Patients with cystic fibrosis; age and sex not specified | 90 mcg | 8 weeks | — |
| Changes in serum retinol, alpha-tocopherol, vitamin C, carotenoids, xinc and selenium after micronutrient supplementation during alcohol rehabilitation 2003 · micronutrient supplement group · Alcohol-dependent patients aged 20 to 60 years without severe liver disease, hospitalized for alcohol rehabilitation | 100 mcg | 3 weeks | — |
| A randomized factorial study of the effects of long-term garlic and micronutrient supplementation and of 2-wk antibiotic treatment for Helicobacter pylori infection on serum cholesterol and lipoproteins 2006 · micronutrient supplementation · Disease-free people in a rural Chinese population; age and sex not specified | 75 mg | 2666 days | — |
| Selenium and iodine supplementation: effect on thyroid function of older New Zealanders 2009 · selenium plus iodine · Adults aged 60–80 years; older Dunedin volunteers with marginal selenium status and mild iodine deficiency | 100 mcg | 90 days | — |
| Effect of L-arginine and selenium added to a hypocaloric diet enriched with legumes on cardiovascular disease risk factors in women with central obesity: a randomized, double-blind, placebo-controlled trial 2012 · L-arginine, selenium and HDEL · Premenopausal women with central obesity | 200 mcg | 6 weeks | — |
| Antioxidant supplements reduced oxidative stress and stabilized liver function tests but did not reduce inflammation in a randomized controlled trial in obese children and adolescents 2014 · antioxidant supplementation · Overweight or obese children and adolescents; mean age 12.7 ± 1.5 years | 50 mcg | 120 days | — |
| Effect of long-term vitamin E and selenium supplementation on urine F2-isoprostanes, a biomarker of oxidative stress 2016 · vitamin E+selenium · men aged 55 years or older (50 or older for African Americans) who were current smokers without COPD | 200 mcg | 3 years | — |
| Derepression of glomerular filtration, renal blood flow and antioxidant defence in patients with type 2 diabetes at high-risk of cardiorenal disease 2020 · vitamin E and selenium · Adults with type 2 diabetes and hypertension and/or microalbuminuria, eGFR >45 mL/min/1.73 m²; non-Caucasian or Caucasian | 20 mcg | 1 year | — |
| Effects of Selenium and/or N-Acetyl-Cysteine Supplementation on Nonthyroidal Illness Syndrome in Hemodialysis Patients: A Factorial Randomized Controlled Trial 2022 · group D · Hemodialysis patients with nonthyroidal illness syndrome; age and sex not specified | 200 mcg | 12 weeks | — |
| Effect of 6 month supplementation with different combinations of an association of antioxidant nutrients on biochemical parameters and markers of the antioxidant defence system in the elderly. The Geriatrie/Min.Vit.Aox Network 1996 · VT (vitamins associated with trace elements) · Elderly nursing-home residents aged 65–103 years who were long-term hospitalized | 100 mcg | 26 weeks | — |
| Effect of a two-year supplementation with low doses of antioxidant vitamins and/or minerals in elderly subjects on levels of nutrients and antioxidant defense parameters 1997 · mineral and vitamin group · Hospitalized adults older than 65 years; baseline deficiencies of vitamin C, zinc and selenium were common | 100 mcg | 2 years | — |
| Effects of supplementation with a combination of antioxidant vitamins and trace elements, at nutritional doses, on biochemical indicators and markers of the antioxidant system in adult subjects 1998 · supplementation group · Adult men aged 45–60 years and women aged 35–60 years | 100 mcg | 26 weeks | — |
| Randomized, double-blind, placebo-controlled trial of selenium supplements among HIV-infected pregnant women in Tanzania: effects on maternal and child outcomes 2008 · selenium group · Pregnant women aged about 27.5 years on average, at 12–27 weeks of gestation, living with HIV in Dar es Salaam, Tanzania | 200 mcg | — | 456 |
| Folate levels determine effect of antioxidant supplementation on micronuclei in subjects with cardiovascular risk 2004 · antioxidant-supplemented group · Middle-aged men: myocardial infarction survivors younger than 50 and healthy controls | 50 mcg | 12 weeks | 53 |
| Antioxidant micronutrients improve intrinsic and UV-induced apoptosis of human lymphocytes particularly in elderly people 2011 · Y2 · Healthy young adults aged 18–22 years | 400 mcg | 60 days | 45 |
| Antioxidant micronutrients improve intrinsic and UV-induced apoptosis of human lymphocytes particularly in elderly people 2011 · O2 · Healthy older adults aged 60–75 years | 400 mcg | 60 days | 45 |
| [Effect of multiple micronutrients supplementation on anti-oxidative activity and oxidized DNA damage of lymphocytes in children] 2005 · supplement group · Chinese children aged 9–11 years, described as healthy and living in a rural area | 200 mcg | 8 weeks | 41 |
| Antioxidant micronutrients improve intrinsic and UV-induced apoptosis of human lymphocytes particularly in elderly people 2011 · C2 · Healthy children aged 8–10 years | 200 mcg | 60 days | 40 |
| Effects of antioxidant supplementation on platelet function: a randomized pair-matched, placebo-controlled, double-blind trial in men with low antioxidant status 1991 · antioxidant-supplemented men · Men with low antioxidant status | 75 mcg | 150 days | 39 |
| The impact of a standardized micronutrient supplementation on PCOS-typical parameters: a randomized controlled trial 2019 · Multinutrient supplementation group · Women aged 19–35 with polycystic ovary syndrome (PCOS) | 70 mcg | 90 days | 30 |
| Consumption of Hen Eggs Enriched with n-3 Polyunsaturated Fatty Acids, Selenium, Vitamin E and Lutein Incites Anti-Inflammatory Conditions in Young, Healthy Participants - A Randomized Study 2022 · 4Nutri group · Young, healthy participants; age range and sex not stated | 60 mcg | 3 weeks | 20 |
| Increase in oxidation resistance of atherogenic serum lipoproteins following antioxidant supplementation: a randomized double-blind placebo-controlled clinical trial 1994 · supplemented group · Healthy men aged 30–58 years who smoked 15–40 cigarettes per day | 100 mcg | 90 days | 20 |
| Effect and Tolerability of a Nutritional Supplement Based on a Synergistic Combination of β-Glucans and Selenium- and Zinc-Enriched Saccharomyces cerevisiae (ABB C1(®)) in Volunteers Receiving the Influenza or the COVID-19 Vaccine: A Randomized, Double-Blind, Placebo-Controlled Study 2021 · ABB C1® group, COVID-19-vaccine cohort · Men and women aged 18 years or older receiving COVID-19 vaccine, recruited from long-stay centers or as healthcare workers at the study centers | 100 mcg | 5 weeks | 18 |
| Oxidative stress in humans during work at moderate altitude 1999 · antioxidant mixture group · U.S. Marines engaged in moderate-altitude cold-weather field training; age and sex not reported | 100 mcg | 4 weeks | 15 |
| Effect and Tolerability of a Nutritional Supplement Based on a Synergistic Combination of β-Glucans and Selenium- and Zinc-Enriched Saccharomyces cerevisiae (ABB C1(®)) in Volunteers Receiving the Influenza or the COVID-19 Vaccine: A Randomized, Double-Blind, Placebo-Controlled Study 2021 · ABB C1® group, influenza-vaccine cohort · Men and women aged 60 years or older receiving influenza vaccine and requiring hospitalization or ambulatory follow-up by palliative support teams | 100 mcg | 30 days | 14 |
| Antioxidant supplementation and tapering exercise improve exercise-induced antioxidant response 2003 · supplemented group (Su) · Triathletes; age, sex and health status not specified | 150 mcg | 6 weeks | 7 |
| Antioxidant supplementation preserves antioxidant response in physical training and low antioxidant intake 2004 · supplemented (S) group · Overloaded triathletes with initially low antioxidant intakes | 150 mcg | 8 weeks | 7 |
| Effect of antioxidant supplementation on urine and blood markers of oxidative stress during extended moderate-altitude training 1999 · antioxidant supplement (S) group · US Marine Corps volunteers undergoing 14 days of winter training at approximately 2700 m | 100 mcg | 2 weeks | — |
| Prophylactic iron supplementation in pregnant women in Norway 2001 · 15 mg iron daily · Non-anaemic pregnant women, allocated at about 10 weeks of pregnancy | 50 mcg | — | — |
| Alterations of the lipid profile after 7.5 years of low-dose antioxidant supplementation in the SU.VI.MAX Study 2005 · antioxidant supplementation · French adults: women aged 35–60 years and men aged 45–60 years | 100 mcg | 2738 days | — |
| Hemolysate thioredoxin reductase and glutathione peroxidase activities correlate with serum selenium in a group of New Zealand men at high prostate cancer risk 2006 · 200 microg Se per day · Men with elevated prostate-specific antigen and a negative prostate biopsy | 200 mcg | 26 weeks | — |
| Hemolysate thioredoxin reductase and glutathione peroxidase activities correlate with serum selenium in a group of New Zealand men at high prostate cancer risk 2006 · 400 microg Se per day · Men with elevated prostate-specific antigen and a negative prostate biopsy | 400 mcg | 26 weeks | — |
| Supranutritional Sodium Selenate Supplementation Delivers Selenium to the Central Nervous System: Results from a Randomized Controlled Pilot Trial in Alzheimer's Disease 2019 · nutritional group · Patients with Alzheimer's disease; age and sex not stated | 960 mcg | 24 weeks | — |